View by Specialty

Trending

PC1124Murray_Graphic_01_WEB
November 22, 2024
3 min read
Save

‘Truly alarming’: Life expectancy gap in the US now up to 20 years

Pulmonology News

SPONSORED CONTENT
Save
SPONSORED CONTENT
November 26, 2024
1 min read
Save

Topline results: Winrevair lowers risk for mortality in patients with advanced PAH

Topline results: Winrevair lowers risk for mortality in patients with advanced PAH

Adults with pulmonary arterial hypertension functional class three or four faced a decreased risk for all-cause mortality or morbidity events with Winrevair vs. placebo, according to phase 3 ZENITH trial topline results.

SPONSORED CONTENT
November 26, 2024
3 min read
Save

Frailty negatively impacts lung function, survival in patients with IPF

Frailty negatively impacts lung function, survival in patients with IPF

Significant predictors of FVC and diffusion capacity of lung for carbon monoxide included frailty, low fat-free mass index and sarcopenia in patients with idiopathic pulmonary fibrosis, according to data published in Respiratory Research.

Trending

PC1124Murray_Graphic_01_WEB
November 22, 2024
3 min read
Save

‘Truly alarming’: Life expectancy gap in the US now up to 20 years

SPONSORED CONTENT
November 25, 2024
4 min read
Save

Life insurance 101: Understand term vs. permanent policies

Life insurance 101: Understand term vs. permanent policies

Physicians generally use life insurance to achieve certain wealth planning goals — from protecting the family against the risk of a breadwinner’s early death to providing an estate for heirs and more.

SPONSORED CONTENT
November 25, 2024
3 min read
Save

Evidence limited for predicting, monitoring COPD exacerbations via wearable devices

Evidence limited for predicting, monitoring COPD exacerbations via wearable devices

PHILADELPHIA — Despite the growing prevalence of wearable devices, more research is needed before they can be used to predict and monitor COPD exacerbations, according to a presentation at the 2024 GOLD COPD International Conference.

SPONSORED CONTENT
November 25, 2024
3 min read
Save

FDA clears investigational new drug application for inhaled nicotine replacement therapy

FDA clears investigational new drug application for inhaled nicotine replacement therapy

The FDA has cleared an investigational new drug application for the RespiRx Nicotine Inhaler (QN-01), an inhaled nicotine replacement therapy, according to a press release.

SPONSORED CONTENT
November 25, 2024
3 min read
Save

Lack of primary care clinician a barrier to lung cancer screening

Lack of primary care clinician a barrier to lung cancer screening

Lack of a primary care provider may hinder an individual’s ability to undergo lung cancer screening, according to results of a quality improvement study.

SPONSORED CONTENT
November 22, 2024
1 min read
Save

1 in 20 adult outpatients hospitalized after RSV diagnosis

1 in 20 adult outpatients hospitalized after RSV diagnosis

Among outpatients with respiratory syncytial virus, one in 20 experienced all-cause hospitalization, according to a recent study.

SPONSORED CONTENT
November 22, 2024
3 min read
Save

‘Truly alarming’: Life expectancy gap in the US now up to 20 years

‘Truly alarming’: Life expectancy gap in the US now up to 20 years

The life expectancy gap in the United States widened to over 20 years in the last 2 decades, with significant variations in life expectancy across diverse populations, study results published in The Lancet revealed.

SPONSORED CONTENT
November 22, 2024
2 min read
Save

Cystic fibrosis triple therapy improves clinical outcomes in N1303K mutation

Cystic fibrosis triple therapy improves clinical outcomes in N1303K mutation

Percent-predicted FEV1 and respiratory-related quality of life improved with 28-day triple therapy in individuals with the N1303K cystic fibrosis transmembrane conductance defect, according to data published in Lancet Respiratory Medicine.

SPONSORED CONTENT
November 22, 2024
2 min read
Save

Even with treatment, patients with COPD regularly become frequent exacerbators

Even with treatment, patients with COPD regularly become frequent exacerbators

BOSTON — Moving from Global Initiative for Chronic Obstructive Lung Disease, or GOLD, group A/B to group E was common among patients starting a new inhaled maintenance medication, according to a presentation at the CHEST Annual Meeting.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails